Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT03498391
Other study ID # 829800
Secondary ID
Status Suspended
Phase Phase 2
First received
Last updated
Start date July 30, 2018
Est. completion date May 2023

Study information

Verified date February 2023
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary aim of this study is to determine whether spatiotemporal characteristics of multisensory evoked potentials can be used as a marker of consciousness (awareness) under anesthesia. The secondary aim is to characterize changes in the characteristics of evoked potentials under anesthesia in both single sensory modality (visual, auditory) and across sensory modalities.


Description:

This is a prospective, dual parallel arm human subject study aimed at determining the relationship between level of sedation (consciousness) and features of multi and uni-sensory evoked potentials with the ultimate goal of developing novel means of detecting consciousness under anesthesia with potential for application to other clinical settings such as brain injury. For this purpose, the investigators have chosen two anesthetics with fundamentally distinct mechanisms of action: propofol and ketamine. The study will involve healthy compensated volunteers. On the day of the study, an EEG cap will be applied to the participant for monitoring brain activity and an intravenous line will be placed for drug administration. Blood pressure, ECG, pulse oxymetry, and end-tidal carbon dioxide (from nasal cannula) will be monitored. Supplemental oxygen will be administered using a nasal cannula. Subjects will then perform the behavioral tasks in the awake state for approximately 1 hour. After this phase is complete, participants will receive either propofol or ketamine (chosen permuted block randomization) using a clinician bolus/infusion strategy titrated to Richmond Agitation-Sedation Scale score of -1 (see above). Once the desired sedation level is achieved, subjects will once again complete the behavioral tasks. After the completion of this phase (approximately 1 hour) the anesthetic dose will be increased to attain Richmond Agitation-Sedation Scale -3 to -4. At this level of sedation subjects will not be able to do the behavioral task and only the evoked potentials will be recorded. Upon completion of this phase (approximately 1 hour), sedation level will be decreased to return the subject to a Richmond Agitation-Sedation Scale of -1 and once again the tasks will be repeated. Finally, the anesthetic infusion will be stopped. Once the Richmond Agitation-Sedation Scale score of 0 is attained, participants will once again perform the behavioral task (approximately 1 hour). This will conclude the experimental phase of the trial. Subjects will be monitored until clinically established discharge criteria are met. This includes adequate respiration, blood pressure, oxygen saturation and activity level. No formal follow-up is required; however, subjects will be called 24 hours after study completion.


Recruitment information / eligibility

Status Suspended
Enrollment 40
Est. completion date May 2023
Est. primary completion date May 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Healthy volunteers ages 18-65 years old - American Society of Anesthesiologists (ASA) Physical Status I or II (i.e. healthy) - Body Mass Index <30 kg/m2 - Easily visible uvula Exclusion Criteria: - Contraindications to administration of either propofol or ketamine - Allergy to either one of the medications or preservative in which it is diluted. - History (or current) seizure disorder - Contraindications to anesthesia - Significant cardiovascular disease (e.g. h/o hypertension, arrhythmias, myocardial infarction, congestive heart failure, congenital heart defects, coronary artery disease) - Increased risk factors for difficult intubation and/or ventilation - Obesity (BMI>=30 kg/m2) - Mallampati class > 2. - History of or current obstructive sleep apnea. - Increased risk of aspiration - Any per oral intake within 8 hours of anesthetic exposure - Conditions that delay gastric emptying (e.g. obesity, hiatal hernia, gastro esophageal reflux disease, pregnancy, etc.) - Pulmonary disease (e.g. chronic obstructive pulmonary disorder, asthma requiring rescue inhaler within last month, emphysema, pulmonary hypertension, pulmonary fibrosis etc). - Neurological disease. Patients with history of strokes, seizures, brain surgery, brain tumor, increased intracranial pressure. - Psychiatric disease. History of or presents of psychosis, schizophrenia, schizo-affective disorder. - Specific Medication Current Use. History of or current intake of antipsychotics or sedatives. - Drug abuse. History of or current use of illegal drugs such as stimulants or depressants. - Pregnancy or breastfeeding - Inability to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propofol
Titration of propofol to minimal and moderate sedation as measured by Richmond Agitation-Sedation Scale with behavioral task performance over several hours.
Ketamine Injectable Product
Titration of ketamine to minimal and moderate sedation as measured by Richmond Agitation-Sedation Scale with behavioral task performance over several hours.

Locations

Country Name City State
United States University of Pennsylvania, Perelman School of Medicine Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Multi-sensory Evoked Responses Measured using Electroencephalography The primary study endpoint is multi-sensory evoked responses measured using EEG in units of millivolts squared per hertz at Richmond Agitation and Sedation Scale scores of 0, -1, -2, -3 and -4. Multisensory evoked responses will be compared to those evoked by each uni-sensory modality (auditory and visual) individually. Evoked responses will be assessed in the frequency domain using spectral analysis techniques which quantify power of each neuronal oscillation (e.g. alpha, delta, theta and gamma) in terms of mV^2/Hz. Analysis will be performed separately during the period before drug administration and at different levels of sedation quantified with RASS scores. The investigators will test the hypothesis that with increasing doses of intravenous anesthetics, audiovisual (multisensory) responses will approximate algebraic sum of neuronal responses elicited by visual and auditory stimuli presented separately. 2-6 hours per subject
Secondary Single Modality Evoked Potentials The secondary endpoint is to use EEG recordings to demonstrate changes in the characteristics of evoked potentials under anesthesia using single sensory modality (visual, auditory) and across sensory modalities. Conventional evoked potentials will be computed as average waveforms aligned with respect to stimulus onset on a channel-by-channel basis. 2-6 hours per subject
See also
  Status Clinical Trial Phase
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Recruiting NCT05991453 - Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial N/A
Completed NCT05656703 - Anesthesia Depth Increases Delirium Incidence N/A
Recruiting NCT03773588 - Entropy and Surgical Pleth Index Guided Closed Loop Target Controlled Infusion Total Intravenous Anesthesia With Propofol N/A
Active, not recruiting NCT06337877 - Assessment of Sedation Depth in ARDS Patients Undergoing Therapeutic Paralysis
Completed NCT03438734 - Comparison of Low Versus Normal Flow Anesthesia on Cerebral Oxygenation and Bispectral Index in Morbidly Obese Patients N/A
Not yet recruiting NCT06427785 - The Effect of Wavelet Index in Monitoring the Sedation Depth of Remimazolam Besylate
Completed NCT06316622 - Examination of The Relationshıp Between Body Mass Index And The Skin-Epidural Space Distance N/A
Recruiting NCT06323616 - The Effect of Anesthesia Depth Monitoring on Emergence Delirium in Pediatrics N/A
Recruiting NCT03476213 - Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming N/A
Recruiting NCT04009018 - Adaptation of Perioperative Satisfaction Scale in Regional Anesthesia and Investigation of Its Psychometric Properties N/A
Completed NCT03521414 - Glasgow Coma Scales and General Anesthesia N/A
Completed NCT03134651 - Preoperative Anxiety at Oocyte Retrieval N/A
Active, not recruiting NCT04826146 - Pediatric Validation of CONOX Monitor During Surgery
Recruiting NCT04788732 - Heart Rate Variability to Quantify General Anesthesia Depth
Recruiting NCT05193747 - The Depth of Paediatric Anaesthesia: Observational Trial
Completed NCT03807297 - TIVA vs Inhalational Mode of Anaesthesia Phase 2
Completed NCT04813952 - The Effect of Minimal Flow Sevoflurane Anesthesia N/A
Completed NCT03503357 - ConsCIOUS2 Study of the Isolated Forearm Technique Commands N/A
Not yet recruiting NCT05254704 - Validation of the French Version of the TEX-Q Questionnaire.